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ABSTRACT
Objective: The objective of this study was to evaluate technical, clinical and angiographic 
results of a nonsurgical series of intracranial aneurysms treated by endovascular approach 
at Hospital das Clínicas of Medical School of Ribeirão Preto - University of São Paulo. 
Method: Between August 2005 and November 2008, 137 aneurysms in 106 patients were 
endovascularly treated. Of these, 101 were unruptured in 75 patients and 36 aneurysms 
in 31 patients were treated during the acute phase. The data were prospectively studied. 
Results: Sixty three aneurysms (46%) were treated with coils alone, 52 (38%) with balloon 
remodeling, 15 (10.9%) with stent remodeling, and 7 (5.1%) with therapeutic occlusion of 
the internal carotid artery. Six clinical complications (5.7%) were related to the procedures, 
3 (2.8%) transitory and 3 (2.8%) permanent. Angiographic follow-up was available for 97 
aneurysms (70.8%), clinical monitoring for 77 patients (72.6%) and telephone contact for 
97 (91.5%). Conclusion: The technical, clinical and angiographic results found in this study 
are similar to those reported in the literature. 
Key words: intracranial aneurysm, endovascular treatment, remodeling technique, 
socioeconomics, complications.
Tratamento endovascular de aneurismas selecionados (maioria não cirúrgicos) em um 
hospital universitário brasileiro
RESUMO
Objetivo: Nosso objetivo foi avaliar os resultados técnicos, clínicos e angiográficos de uma 
série de aneurismas intracranianos não cirúrgicos tratados por via endovascular no Hospital 
das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo 
e comparar com os dados disponíveis na literatura atualmente. Método: Entre agosto de 
2005 e novembro de 2008, 137 aneurismas foram tratados por via endovascular em 106 
pacientes. Destes, 101 eram não rotos em 75 pacientes e 36 aneurismas foram tratados 
em 31 pacientes durante a fase aguda de ruptura. Os dados foram incluídos de maneira 
prospectiva. Resultados: Sessenta e três aneurismas (46%) foram tratados com técnica 
simples, 52 (38%) com remodelagem por balão, 15 (10,9%) com remodelagem por stent e 
7 (5,1%) por oclusão terapêutica da carótida interna. Seis complicações clínicas ocorreram 
(5,7%), 3 (2,8%) transitórias e 3 (2,8%) permanentes. Seguimento angiográfico foi realizado 
para 97 aneurismas (70,8%), clínico para 77 pacientes (70,8%) e contato telefônico para 97 
pacientes (91,5%). Conclusão: Os resultados encontrados nesta série, em termos técnicos, 
clínicos e angiográficos, são semelhantes aos encontrados na literatura. 
Palavras-chave: aneurisma intracraniano, tratamento endovascular, técnica de remo-
delagem, fatores socioeconômicos, complicações.
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Endovascular treatment of cerebral aneurysms under-
went a revolution after the introduction of controlled de-
tachable coils1. The first series available in the literature 
reported the results only for aneurysms not suited for 
surgery2,3. In 2002 the ISAT study4 demonstrated at level 1 
of evidence that ruptured cerebral aneurysms significant-
ly benefited from endovascular treatment, changing the 
treatment of cerebral aneurysms all over the world. Un-
fortunately, this achievement may not be reproducible in 
many developing countries, since there are no many pub-
lications showing their results5 and many factors hinder 
the development of the technique. 
Initially restricted to small neck aneurysms, balloon6 
and stent7,8 remodeling, allied to therapeutic occlusion of 
the internal carotid artery (ICA)9 have allowed the treat-
ment of the majority of intracranial aneurysms.
Our study comprises a population of most non-sur-
gical aneurysms treated by endovascular approach at the 
Medical School of Ribeirão Preto, University of São Pau-
lo, after the recent establishment of interventional neu-
roradiology discipline. The patients included in the study 
were considered unsuitable for surgical approach by the 
vascular neurosurgeons of the institution. Factors related 
to complications and treatment stability have been ana-
lyzed and compared to the results in the literature. 
METHOD
This prospective study period began with the first pa-
tient treated in August 2005 and ended with the last treat-
ment included in November 2008. Collected data includ-
ed demographic information, aneurysms characteristics, 
treatment strategy, angiographic results, clinical condi-
tion at admission and discharge, clinical follow-up and 
telephone interview. Retreatments and their results were 
also included.
This research was approved by the ethical committee 
of our institution and all the patients had their inclusion 
in the study authorized by an informed consent.
The patients were divided into two groups to analyze 
the clinical results: with unruptured and ruptured aneu-
rysms. Technical results and stability were analyzed con-
sidering the entire group.
Inclusion criteria were: risky location or inaccessible 
for surgery; patients with critical clinical conditions; mul-
tiple aneurysms, one of which already treated surgical-
ly, patients with residual aneurysm after surgery, and pa-
tient’s option for endovascular treatment.
Aneurysms considered suitable for surgery were ex-
cluded by the vascular neurosurgical team, without the 
participation of the interventional neuroradiology in this 
decision.
All procedures were performed on a monoplane an-
giographic system without 3-dimensional reconstruction.
The procedures were performed under general anes-
thesia (GA) and a 5000UI bolus of heparin was admin-
istered followed by 2500-3000UI continuously after the 
digital subtracted angiography (DSA). In the absence 
of complications, heparin was ceased at the end of the 
procedure.
Antiplatelets were not used as routine preparation for 
the endovascular treatment of ruptured or unruptured 
aneurysms. However, aneurysms treated with stent re-
modeling received 300mg aspirin and 75mg clopidogrel 
per day 5 days before the procedure, continued for 6 
months, followed by aspirin alone for 1 year.
After analyzing the aneurysm, one of these 4 thera-
peutic alternatives was chosen: [1] coils alone for small 
neck aneurysms, [2] balloon remodeling for wide neck 
aneurysms, [3] stent remodeling for large and giant wide 
neck aneurysms or, [4] therapeutic occlusion for aneu-
rysms unsuited for selective treatment.
The devices used for endovascular procedures in our 
hospital are purchased through public licitation. The 
coils used were GDC (Boston Scientific, Fremont, Ca-
lif ) and Saphire (ev3, Irvine, Calif ). Remodeling balloons 
were Sentry (Boston Scientific), Hyperglide and Hyper-
form (ev3). Stent remodeling was performed with Neu-
roform3 (Boston Scientific).
DSA was performed 6, 18 and 36 months after the 
treatment. At the time of each angiographic control, a 
clinical assessment was conducted.
Angiographic occlusion rate were graduated as: com-
plete (class-I), neck-remnant (class-II) or incomplete 
(class-III) according to the Raymond’s classification10. 
They were clinically evaluated according to the modified 
Rankin’s scale (mRS). After inclusion of all patients in the 
study, we have tried to contact each one of them by tele-
phone to assess their clinical condition.
At the end of the 36-month period, in the absence of 
recurrence, the patient was discharged. For major recur-
rences, a retreatment was performed. In our casuistic, all 
aneurysms with major recurrences were retreated.
Factors possibly related to complications were ana-
lyzed such as: patients age, aneurysm size and neck size, 
and type of treatment, as well as factors possibly related 
to recurrence such as: unsatisfactory angiographic result, 
aneurysm size and neck, and type of treatment. Statistical 
analyses were performed using Fisher’s exact test, with a 
5% significance level.
RESULTS
Patients and aneurysms
From August 2005 to November 2008, 137 saccular 
aneurysms were treated in 106 patients, 101 unruptured 
in 75 patients and 36 aneurysms in 31 patients were treat-
ed during the acute phase of rupture. Patients included 
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84 female and 22 male, their ages ranging from 22 to 80 
years (mean age, 54 years) (Table 1).
A hundred and ten aneurysms were located in the an-
terior (80.3%) and 27 (19.7%) in the posterior circulation; 
18 (13.1%) in the cavernous segment, 35 (28.5%) were 
paraclinoid and only 13 (9.5%) were located in the mid-
dle cerebral artery (MCA) and 10 (7.3%) in the anterior 
communicating artery (Acom).
We found 58 (42.3%) small aneurysms (<7 mm), 47 
(34.3%) medium (7-12 mm), 14 (10.2%) large (13-24 mm) 
and 18 (13.1%) giant (≥25 mm). The mean-size was 10.8 
mm. Out of the 101 unruptured aneurysms, 41 (40.6%) 
were small, 29 (28.7%) medium, 13 (12.9%) large, and 18 
(17.8%) giant. Among the 36 ruptured aneurysms, 17 
(47.2%) small, 18 (50%) medium, and 1 (2.8%) large. Data 
regarding aneurysms characteristics and locations are 
demonstrated in Table 2.
Treatment strategy
Sixty three aneurysms (46%) were treated with coils 
alone, 52 (38%) with balloon remodeling, 15 (10.9%) with 
stent remodeling and 7 (5.1%) with therapeutic occlu-
sion (Table 2). Out of the 101 unruptured aneurysms, 33 
(32.7%) were treated with coils alone, 46 (45.5%) with bal-
loon remodeling, 15 (14.9%) with stent remodeling and 
7 (6.9%) with therapeutic occlusion. Among the 36 rup-
tured aneurysms, 30 (84.2%) were treated with coils alone, 
and 6 (15.8%) with balloon remodeling.
Complications
There were 9 (6.6%) technical complications, 6 (4.4%) 
asymptomatic and 3 (2.2%) symptomatic. Complications 
were thromboembolic for 5 aneurysms, stretched coils 
for 2, rupture for 1 and infected hematoma at the punc-
ture site for 1. 
No technical complications occurred for aneurysms 
treated with stent remodeling or therapeutic occlusion. 
Four (7.7%) technical complications occurred in the 
group of aneurysms treated with balloon remodeling and 
5 (7.9%) in the group treated with coils alone.
Aneurysm (p=0.7138) or neck size (p=0.3165), as well 
as treatment strategy (p=0.8674) did not influence the 
complication rates as shown in Table 3.
Clinical complications occurred in 6 (5.7%) patients 
among the 106, 3 (2.8%) transitory and 3 (2.8%) perma-
nent. Two permanent clinical complications were due 
to ischemia related to thromboembolic event and a third 
one due to a stretched coil in a patient with ruptured 
aneurysm who was kept under antiplatelets, and had a 
hemorrhagic complication during a ventricular shunt 
placement.
There were no difference in terms of clinical compli-
cation rates among the age groups (p=0.8874) (Table 4).
Table 1. Patients.
Age group  
   <29 years 3 (2.8%)
   30 to 39 years 10 (9.4%)
   40 to 49 years 23 (21.7%)
   50 to 59 years 36 (34%)
   60 to 69 years 23 (21.7%)
      ≥70 years 11 (10.4%)
Gender  
   Female 84 (79.2%)
   Male 22 (20.8%)
Ruptured / Unruptured
   Unruptured 75 (70.8%)
   Ruptured 31 (29.2%)
Table 2. Aneurysms.
Size  
   <7 mm 42.3% (58)
   7-12 mm 34.3% (47)
   13-24 mm 10.2% (14)
      ≥25 mm 13.1% (18)
Neck  
      ≤4 mm 39.4% (54)
   >4 mm 60.6% (83)
Location  
   Anterior circulation
      Acom 7.3% (10)
      Pericallosal artery 1.5% (2)
      MCA 9.5% (13)
      Anterior choroidal artery 1.5% (2)
      ICA bifurcation 2.9% (4)
      Ophthalmic artery 15.3% (21)
      Pcom 18.2% (25)
      Superior hypophyseal artery 10.2% (14)
      Cavernous segment 13.1% (18)
      Persistent trigeminal artery 0.7% (1)
   Posterior circulation  
      Basilar tip 10.9% (15)
      Basilar trunk 3.6% (5)
      PICA 2.2% (3)
      Posterior cerebral artery 1.5% (2)
      Superior cerebellar artery 1.5% (2)
Treatment strategy  
   Simple technique 46% (63)
   Balloon remodeling 38% (52)
   Stent remodeling 10.9% (15)
   Therapeutic occlusion 5.1% (7) 
Acom: anterior co mmunicating artery; MCA: middle cerebral artery; ICA: 
internal carotid artery; Pcom: posterior co mmunicating artery; PICA: 
posterior inferior cerebellar artery.
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Clinical results
Out of the 75 patients harboring 101 unruptured an-
eurysms, 72 (96%) were independent at the admission 
(mRS 0-2). Upon hospital discharge, there was clinical 
deterioration in 1 patient (1.3%). 
Clinically, 61 patients (81.3%) were evaluated once, 22 
(29.3%) twice and 4 (5.3%) three times (mean follow-up, 
12.1 months). Comparing to admission, there was clini-
cal deterioration in 1 patient who became dependent, and 
improvement of 1 patient who became independent.
Telephone interviews were possible for 74 (98.7%) of 
the patients harboring unruptured aneurysms (mean fol-
low-up, 22 months), where 70 (94.6%) were independent. 
Comparing to admission, one patient became indepen-
dent, and one patient continued to be dependent. Anoth-
er patient became dependent after meningioma surgery 
and one died of heart attack.
Subarachnoid hemorrhage for ruptured aneurysms, 
was graded as Fisher 1 for 1 (3.2%) patient, 2 for 4 (12.9%) 
patients, 3 for 7 (22.6%) and 4 for 19 (61.3%). According 
to Hunt and Hess’s scale (HH), 19 (61.3%) were in good 
grade (HH 1-3) and 12 (38.7%) bad grade (HH 4-5).
At discharge, 16 patients (51.6%) were independent, 6 
(19.4%) dependent and 9 (29%) died.
Among the 19 patients in good clinical conditions, 
15 (78.9%) were independent at the hospital discharge, 
2 (10.5%), were dependent and 2 (10.5%) died, where-
as among the 12 patients in poor conditions, 1 (8.3%) 
was independent at the time of discharge, 4 (33.3%) were 
dependent and 7 (58.3%) died. Among the 31 patients 
treated in this group, 16 (72.7% of survivors) were clini-
cally evaluated once, 8 (25.8%) twice and 1 (3.2%) three 
times and 14 were independent (mean follow-up, 14.5 
months).
All of the 22 surviving patients after discharge could 
be contacted by telephone (mean follow-up, 21.5 months). 
Eighteen (58.06%) were independent, 2 dependent and 
2 died of clinical complications. Among the 19 patients 
in good conditions, only 1 was dependent, representing 
84.2% of good results. No patient had any rebleeding ep-
isode after aneurysm treatment.
Table 3. Technical complications.
  Complications % (n)
Technical complications 6.6% (9)
Symptomatic 2.2% (3)
Asymptomatic 4.4% (6)
Aneurysm size
   <7 mm 8.6% (5)
   7-12 mm 6.4% (3)
   13-24 mm 7.1% (1)
   ≥25 mm 0% (0)
p=0.7138
Neck size
      ≤4 mm 9.3% (5)
   >4 mm 4.8% (4)
p=0.3165
Treatment strategy
   Coils alone 7.9% (5)
   Balloon remodeling 7.7% (4)
   Stent remodeling 0% (0)
   Therapeutic occlusion 0% (0)
 p=0.8674
Table 4. Clinical complications.
 Complications % (n)
Clinical complications 5.7% (6)
Permanent 2.8% (3)
Transitory 2.8% (3)
Age
   <40 0% (0)
   40-49 4.3% (1)
   50-59 8.3% (3)
   60-69 4.3% (1)
      ≥70 9.1% (1)
 p=0.8874
Table 5. Major recurrences.
 Major recurrences % (n)
Total 8.2% (8)
Immediate result
   Class I 2.4% (2)
   Class II 50% (4)
   Class III 40% (4)
p<0.0001
Aneurysm size
   <7 mm 0% (0)
   7-12 mm 3.3% (1)
   13-24 mm 16.7% (2)
   ≥25 mm 33.3% (5)
p<0.0001
Neck size
   <4 mm 0% (0)
   ≥4 mm 13.1% (8)
p=0.0241
Treatment strategy
   Coils alone 10.2% (4)
   Balloon remodeling 10.0% (4)
   Stent remodeling 0% (0)
   Therapeutic occlusion 0% (0)
 p=0.8674
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Angiographic results and follow-up
Angiographic result class I was obtained at the end 
of treatment for 118 aneurysms (86.13%), class II for 9 
(6.57%) and class III for 10 (7.30%).
Angiographic controls were carried out for 97 aneu-
rysms (76.98% of the surviving patients) (mean follow-up, 
12.3 months). Thirty-six aneurysms (26.28% of total) were 
controlled twice and 7 (5.11%) three times.
Among the 97 controlled aneurysms, 8 (8.25%) were 
retreated. As all major recurrences were retreated, this 
group was considered for analysis. No complications oc-
curred in the retreatments.
Retreatment had strong correlations with immediate 
angiographic result (p<0.0001), aneurysm size (p<0.0001) 
and neck size (p=0.0241), as shown in Table 5.
No retreatment was required for the 13 aneurysms 
treated by stent remodeling or for the 5 aneurysms treated 
by therapeutic occlusion. Among the 39 aneurysms treat-
ed by coils alone, 4 (10.3%) required retreatment; among 
the 40 treated by balloon remodeling, 4 (10%) required re-
treatment, without statistical relevance (p=0.8518). How-
ever, when only large and giant aneurysms were analyzed, 
we verified that 4 (66.7%) of the 6 aneurysms treated by 
coils alone and 3 (42.9%) of the 7 treated by balloon re-
modeling required retreatment. None of the 9 aneurysms 
treated with stent remodeling, or of the 5 aneurysms with 
therapeutic occlusion, required retreatment. The treat-
ment was more stable for stent remodeling and therapeu-
tic occlusion in this group (p=0.0061).
DISCUSSION
Representing a series of most non-surgical, a large 
number of our patients were older than 60 years-old 
(32.1%). Frequent locations such as MCA and Acom were 
rarely found, and difficult surgical locations were more 
common, such as posterior circulation, paraclinoid and 
cavernous aneurysms. Among the patients treated during 
the acute phase, 38.7% presented poor clinical condition.
There were a large number of aneurysms treated with 
balloon (38%) and stent remodeling (10.9%). In the group 
of unruptured aneurysms, only 32.7% were treated with 
coils alone, 45.5% with balloon remodeling, 14.9% with 
stent and 6.9% with therapeutic occlusion. 
The first series available in the literature report on the 
results of aneurysm treatment using only the simple tech-
nique, restricted to small neck aneurysms. After the intro-
duction of balloon remodeling by Moret6, the emboliza-
tion of wide-necked aneurysms became possible in safe 
conditions. Stent remodeling was initially performed with 
balloon expandable stents, with high complication rates7. 
Self-expandable stents adapted for intracranial circulation 
have recently shown better results8 and became an im-
portant device in the treatment of intracranial aneurysms.
The therapeutic occlusion of the ICA was described 
in 19749 to deal with complex aneurysms. The occlusion 
test protocol varies markedly in the literature. We used 
the angiographic test occlusion described by Abud et al.11, 
without clinical evaluation. 
The evaluation of the endovascular treatment of un-
ruptured aneurysms, in the recent ATENA study12, pre-
sented a proportion of endovascular techniques similar 
to ours, in which 98.4% of the aneurysms were selective-
ly treated, 54.5% with coils alone, 37.3% with balloon re-
modeling and 7.3% with stent remodeling. 
According to our results, thromboembolic events 
were the most frequent complication, while the hemor-
rhagic ones were rare.
Thromboembolic complications incidence ranges be-
tween 2.5% and 11% in the literature, with clinical conse-
quences in 2.5% to 5.5% of the patients13,14. 
Embolic events related to embolization were initial-
ly treated with thrombolytic agents, with disastrous con-
sequences to patients with ruptured aneurysms4. Anti-
platelets, abxicimab15 and tirofiban16, have been recently 
introduced dealing with these complications with good 
results.
Aneurysm perforation is the most feared complica-
tion; however, it does not always have serious conse-
quences. 
In a meta-analysis of 17 retrospective studies17, it was 
found a higher risk of perforation for ruptured aneurysms 
(4.1%) compared to unruptured ones (0,5%), leading to a 
morbi-mortality of 38% and 29% respectively.
We have found no statistically significant differenc-
es in terms of complications for the different techniques. 
No permanent complications occurred in the groups of 
aneurysms treated with stent remodeling or therapeutic 
occlusion, but the small number of patients included in 
these groups should be considered. The rates of techni-
cal complications were similar for aneurysms treated with 
coils alone and balloon remodeling.
In Spelle’s18 recent review of the available publica-
tions on the endovascular treatment of unruptured an-
eurysms, the morbidity rate associated with procedures 
ranged between 3 and 6%, with 1.5% mortality. In the AT-
ENA study12 the morbidity-mortality rates were 1.7 and 
1.4% respectively. In our study we found 1.3% permanent 
morbidity and 0% mortality related to the procedures for 
unruptured aneurysms.
In the ISAT study4, 88% of the included patients were 
in good conditions and 75% were independent after treat-
ment. These findings are similar to our population of rup-
tured-aneurysm patients in good conditions, in which 
78.9% were independent at the discharge and 84.2% in 
the follow-up.
The incidence of angiographic recurrence varies in 
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the literature, between 14.7% and 33.6%19,20. Retreatment 
rate is more stable, around 10%20,21, and is related to larg-
er recurrences.
Piotin19 published a study about aneurysm recurrence, 
evaluating 255 selectively embolized aneurysms with at 
least one angiographic control. Seventy-three aneurysms 
(28.6%) presented recurrence and 14 (5.5%) were retreat-
ed. The length of follow-up was the most important factor.
Raymond20 studied 501 ruptured aneurysms, and 
found recurrence in 33.6% of the cases. Major recurrenc-
es were found in 20.7% and half of them were retreated 
(10.2%). The factors implied with recurrence were aneu-
rysms treated in the acute stage, aneurysm size, neck size, 
incomplete immediate result and follow-up duration.
In the angiographic follow-up of the ISAT study22, re-
treatment was necessary for 10.6% of the patients that 
were submitted to control angiograms.
If only large and giant aneurysms are considered, 
which represent a challenge for the endovascular tech-
nique due to their high rate of recanalization23, we have 
found that treatment with stent remodeling and thera-
peutic occlusion of the ICA were statistically more sta-
ble than simple technique and balloon remodeling. How-
ever, these groups were smaller than the groups of an-
eurysms treated with balloon remodeling or by simple 
techniques. The development of new devices such as the 
flow-diverter stents may improve the stability over time 
in these groups24. 
Our retreatment rate was 8.2% considering the 97 an-
eurysms that were submitted to at least one angiographic 
control and is similar to other results in the literature.
Although recurrence rate is always brought to atten-
tion in the discussion of endovascular embolization, it is 
well established in the literature that complications relat-
ed to retreatment are rare.
A recent study25 reported 100 retreated aneurysms in 
99 patients and found thromboembolic events in 3 pro-
cedures, without clinical implications.
The contribution of endovascular therapy in dealing 
with cerebral aneurysms is undeniable. Our series of pa-
tients with high surgical risk showed good results and 
reveals that, in our context, embolization can be safe-
ly applied. 
In conclusion, endovascular treatment is a viable op-
tion within the Brazilian public health care system and 
must be taken into account when treatment options are 
discussed for such patients. The results for our series of 
predominating non-surgical aneurysms are similar to 
those available in current publications.
Aneurysm size, neck size, patient age and treatment 
strategy did not alter the complication rates.
Sac and neck dimensions as well as immediate angio-
graphic results are related to recurrence. 
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